Alla studier
AvslutadInterventionell

Biologically adaptive radiotherapy for oropharyngeal cancer

Radiotherapy is a standard treatment for throat cancer, but sometimes the tumour comes back in the same spot. Doctors want to see if adapting radiotherapy to each patient can improve cure rates. In this study, patients have a specialised MRI scan before starting treatment and another scan after two weeks of radiotherapy. These scans show how well the cancer is responding. If the tumour is shrinking as hoped, patients carry on with standard radiotherapy. If the cancer is responding more slowly, doctors increase the radiation dose for the remaining four weeks. Researchers want to see if this tailored approach is practical to run in hospitals and whether it keeps cancer away without causing too many extra side effects. Patients are monitored closely throughout treatment to support their recovery and quality of life.

Överblick

Status
Avslutad
Sponsor
NHS Större Glasgow och Clyde
Inskrivningsmål
20
Starta
24 aug 2023
Beräknad slutförande
31 Oct 2025

Vad handlar denna studie om?

Oropharyngeal cancer is a type of head and neck cancer that affects the back of the throat, including the tonsils and the base of the tongue. The standard treatment is usually a six-week course of radiotherapy. While this cures many people, some tumours do return in the exact same place. Doctors know that giving a higher radiation dose can destroy stubborn cancer cells, but giving higher doses to everyone is unnecessary and causes extra side effects.

To find the right balance, researchers are using a technique called diffusion-weighted MRI. This special scan looks at how water molecules move inside tissues, which reveals whether cancer cells are dying. Patients have one scan before starting radiotherapy and another after two weeks of treatment. This allows doctors to see very early on how the cancer is reacting.

If the two-week scan shows the tumour is shrinking well, the patient continues with standard radiotherapy. If the scan suggests the cancer is resisting the treatment, the care team changes the treatment plan to deliver a higher, more targeted dose of radiation for the remaining weeks.

Because this personalised method is new, this study is testing how smoothly these mid-treatment adjustments can be made in regular hospital practice. Researchers are also tracking side effects and daily wellbeing to ensure the higher dose is safe and manageable for patients.

Viktiga punkter

  • The trial tests whether adjusting radiotherapy halfway through treatment improves cure rates for throat cancer.
  • Special MRI scans are taken before treatment and after two weeks to see how the tumour is responding.
  • Only patients whose tumours are slow to shrink will receive an increased dose of radiotherapy.
  • The study takes place at the Beatson West of Scotland Cancer Centre in the UK.
  • Taking part is voluntary, and you can leave the study at any time without affecting your NHS care.

Vem kan vara berättigad?

This trial is open to adults aged 18 and over who have been diagnosed with advanced throat cancer (stages III, IVa, or IVb) that has not spread to distant parts of the body. It is designed for people who are due to receive radiotherapy on its own as their primary curative treatment, rather than having surgery or chemotherapy first.

Because different types of throat cancer respond differently to treatment, this study focuses on specific groups: people whose cancer is not linked to the human papillomavirus (HPV), or people with HPV-positive cancer who also have a heavy history of smoking.

You will not be able to join if your cancer started outside the back of the throat, if you have already had surgery to remove the tumour, or if you have received head and neck radiotherapy in the past. People who cannot safely have an MRI scan (for example, due to certain metal implants) are also unable to take part.

Kan denna studie passa dig?

Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.

  1. I am aged 18 or over.
  2. I have been diagnosed with stage III or IV throat (oropharyngeal) cancer.
  3. My cancer has not spread to distant parts of my body.
  4. I am scheduled to have radiotherapy alone (without chemotherapy or prior surgery) as my main treatment.
  5. I am able to safely have MRI scans.
Svara på varje fråga för att se ditt resultat.

Vad innebär deltagande?

Taking part lasts for the duration of your radiotherapy, which is usually six weeks, followed by regular check-ups. Before treatment begins, you will have a specialised MRI scan, routine blood tests, and possibly a small tissue sample (biopsy) taken. You will then start your daily radiotherapy sessions from Monday to Friday.

After two weeks of treatment, you will have a second MRI scan. If your tumour is responding well, you will finish your treatment using the standard radiotherapy plan. If the scan shows the tumour needs extra treatment, your medical team will design a new plan giving a higher radiation dose over the final four weeks. Throughout your care and during recovery, you will attend regular review appointments to discuss side effects, check your throat, and complete short questionnaires about your daily wellbeing.

Potentiella risker och fördelar

A potential benefit of joining this study is that receiving a higher dose of radiation could give you a better chance of curing the cancer or stopping it from coming back. You will also receive extra monitoring and close support from the specialist research team. However, radiotherapy to the head and neck causes well-known side effects, including severe tiredness, painful mouth sores, skin redness, dry mouth, taste loss, and difficulty swallowing (which may require a temporary feeding tube). A higher dose might slightly increase the risk or severity of these side effects, although modern planning helps shield healthy tissue. Joining the trial is entirely voluntary, and you can withdraw at any point without your standard NHS treatment being affected.

Platser (1)

Vissa platsangivelser är ungefärliga. Vi arbetar på att förbättra detta — vänligen kontrollera med testteamet innan du reser.
  • Beatson West of Scotland Cancer Centre
    Endast stad
    Glasgow, Scotland

Vanliga frågor

Will the higher dose of radiotherapy hurt during the session?

No. Radiotherapy itself is completely painless while it is being delivered, much like having an ordinary X-ray. Side effects such as a sore throat build up gradually over several weeks.

Can I choose whether I get the higher radiotherapy dose?

No. The decision is based strictly on what your two-week MRI scan shows. If your cancer is already shrinking well, a higher dose is not needed and would only cause unnecessary side effects.

What happens if I cannot tolerate the extra radiation?

Your safety comes first. The medical team tracks your symptoms closely. If side effects become too severe, your doctor can adjust your treatment plan or pause therapy to help you recover.

Do I have to pay for any of the extra scans or care?

No. All study scans, treatments, and appointments are provided through the NHS and funded by the research charity at no cost to you.

What is the difference between a normal MRI and the scan used in this trial?

The diffusion-weighted MRI used in this study looks at the microscopic movement of water in your cells. This gives doctors early clues about whether tumour cells are dying before changes can be seen on a standard scan.

Hur du får reda på mer

Ann Shaw

Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.

Diskussion

Gemenskapsdiskussion

Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.